Clinical trial
Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer
NCT00023985 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00023985 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer |
| Official title | Vaccination With Autologous Tumor Lysate-Pulsed Dendritic Cells - Phase I |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Procedure |
| Interventions | autologous tumor cell vaccine, therapeutic autologous dendritic cells, conventional surgery |
| Start date | Jan 1, 2001 |
| Primary completion | Jul 1, 2003 |
| Completion | Aug 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 7, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: